1. Home
  2. BOCN vs KZR Comparison

BOCN vs KZR Comparison

Compare BOCN & KZR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BOCN
  • KZR
  • Stock Information
  • Founded
  • BOCN 2021
  • KZR 2015
  • Country
  • BOCN United States
  • KZR United States
  • Employees
  • BOCN N/A
  • KZR N/A
  • Industry
  • BOCN Blank Checks
  • KZR Biotechnology: Pharmaceutical Preparations
  • Sector
  • BOCN Finance
  • KZR Health Care
  • Exchange
  • BOCN Nasdaq
  • KZR Nasdaq
  • Market Cap
  • BOCN 75.5M
  • KZR 65.3M
  • IPO Year
  • BOCN 2021
  • KZR 2018
  • Fundamental
  • Price
  • BOCN $11.45
  • KZR $7.53
  • Analyst Decision
  • BOCN
  • KZR Hold
  • Analyst Count
  • BOCN 0
  • KZR 2
  • Target Price
  • BOCN N/A
  • KZR $20.00
  • AVG Volume (30 Days)
  • BOCN 24.1K
  • KZR 60.4K
  • Earning Date
  • BOCN 01-01-0001
  • KZR 11-12-2024
  • Dividend Yield
  • BOCN N/A
  • KZR N/A
  • EPS Growth
  • BOCN N/A
  • KZR N/A
  • EPS
  • BOCN 0.06
  • KZR N/A
  • Revenue
  • BOCN N/A
  • KZR N/A
  • Revenue This Year
  • BOCN N/A
  • KZR N/A
  • Revenue Next Year
  • BOCN N/A
  • KZR $66.68
  • P/E Ratio
  • BOCN $179.86
  • KZR N/A
  • Revenue Growth
  • BOCN N/A
  • KZR N/A
  • 52 Week Low
  • BOCN $10.74
  • KZR $5.20
  • 52 Week High
  • BOCN $11.70
  • KZR $11.40
  • Technical
  • Relative Strength Index (RSI)
  • BOCN 41.75
  • KZR 49.59
  • Support Level
  • BOCN $11.45
  • KZR $7.27
  • Resistance Level
  • BOCN $11.50
  • KZR $7.50
  • Average True Range (ATR)
  • BOCN 0.01
  • KZR 0.48
  • MACD
  • BOCN -0.00
  • KZR -0.08
  • Stochastic Oscillator
  • BOCN 8.57
  • KZR 40.00

About BOCN Blue Ocean Acquisition Corp

Blue Ocean Acquisition Corp is a blank check company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses.

About KZR Kezar Life Sciences Inc.

Kezar Life Sciences Inc is a clinical-stage biotechnology company. It is engaged in discovering and developing novel small molecule therapeutics to treat unmet needs in autoimmunity and cancer. The pipeline consist of product candidates such as Zetomipzomib (KZR-616), and KZR-261.

Share on Social Networks: